| Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation ZB Ding, B Hui, YH Shi, J Zhou, YF Peng, CY Gu, H Yang, GM Shi, AW Ke, ... Clinical Cancer Research 17 (19), 6229-6238, 2011 | 204 | 2011 |
| Proteasome inhibitor interacts synergistically with autophagy inhibitor to suppress proliferation and induce apoptosis in hepatocellular carcinoma B Hui, YH Shi, ZB Ding, J Zhou, CY Gu, YF Peng, H Yang, WR Liu, ... Cancer 118 (22), 5560-5571, 2012 | 85 | 2012 |
| Targeting autophagy for the treatment of liver diseases HM Ni, JA Williams, H Yang, YH Shi, J Fan, WX Ding Pharmacological research 66 (6), 463-474, 2012 | 80 | 2012 |
| Sequestosome 1/p62 protein is associated with autophagic removal of excess hepatic endoplasmic reticulum in mice H Yang, HM Ni, F Guo, Y Ding, YH Shi, P Lahiri, LF Fröhlich, T Rülicke, ... Journal of Biological Chemistry 291 (36), 18663-18674, 2016 | 79 | 2016 |
| Basal autophagy and feedback activation of Akt are associated with resistance to metformin-induced inhibition of hepatic tumor cell growth H Yang, YF Peng, HM Ni, Y Li, YH Shi, WX Ding, J Fan PLoS One 10 (6), e0130953, 2015 | 19 | 2015 |
| Autophagy and Cancer Drug Discovery H Yang, JA Williams, Y Hou, M Xia, YH Shi, J Fan, WX Ding Autophagy and Cancer, 225-254, 2013 | 2 | 2013 |
Wen-Xing DingUniversity of Kansas Medical CenterVerified email at kumc.edu
